ACS Chemical Biology
Page 14 of 16
evidence from endocrine and gene expression
mobility in living cells: the importance of ligand
1
2
3
4
5
6
7
8
studies, Arch. Gen. Psychiatry 68, 901-910.
affinity, Mol Cell Biol 23, 1922-1934.
34. Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione,
K. M., O'Leary, J. C., 3rd, Fontaine, S. N., Breydo, L.,
Zhang, B., Li, P., Wang, L., Cotman, C., Paulson, H. L.,
Muschol, M., Uversky, V. N., Klengel, T., Binder, E.
B., Kayed, R., Golde, T. E., Berchtold, N., and Dickey,
C. A. (2013) Accelerated neurodegeneration through
chaperone-mediated oligomerization of tau, J. Clin.
Invest. 123, 4158-4169.
35. Sabbagh, J. J., O'Leary, J. C., 3rd, Blair, L. J.,
Klengel, T., Nordhues, B. A., Fontaine, S. N., Binder,
E. B., and Dickey, C. A. (2014) Age-associated
epigenetic upregulation of the FKBP5 gene
selectively impairs stress resiliency, PloS one 9,
e107241.
36. Hartmann, J., Wagner, K. V., Liebl, C., Scharf, S.
H., Wang, X. D., Wolf, M., Hausch, F., Rein, T.,
Schmidt, U., Touma, C., Cheung-Flynn, J., Cox, M. B.,
Smith, D. F., Holsboer, F., Muller, M. B., and Schmidt,
M. V. (2012) The involvement of FK506-binding
protein 51 (FKBP5) in the behavioral and
neuroendocrine effects of chronic social defeat
stress, Neuropharmacology 62, 332-339.
43. Bledsoe, R. K., Montana, V. G., Stanley, T. B.,
Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T.
G., Parks, D. J., Stewart, E. L., Willson, T. M.,
Lambert, M. H., Moore, J. T., Pearce, K. H., and Xu,
H. E. (2002) Crystal structure of the glucocorticoid
receptor ligand binding domain reveals a novel mode
of
receptor
dimerization
and
coactivator
recognition, Cell 110, 93-105.
9
44. Kirschke, E., Goswami, D., Southworth, D.,
Griffin, P. R., and Agard, D. A. (2014) Glucocorticoid
receptor function regulated by coordinated action of
the Hsp90 and Hsp70 chaperone cycles, Cell 157,
1685-1697.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
45. Lorenz, O. R., Freiburger, L., Rutz, D. A., Krause,
M., Zierer, B. K., Alvira, S., Cuellar, J., Valpuesta, J.
M., Madl, T., Sattler, M., and Buchner, J. (2014)
Modulation of the Hsp90 chaperone cycle by a
stringent client protein, Molecular cell 53, 941-953.
46. Cui, J., Hollmen, M., Li, L., Chen, Y., Proulx, S. T.,
Reker, D., Schneider, G., and Detmar, M. (2017) New
use of an old drug: inhibition of breast cancer stem
cells by benztropine mesylate, Oncotarget 8, 1007-
1022.
47. Hapgood, J. P., Avenant, C., and Moliki, J. M.
(2016) Glucocorticoid-independent modulation of
GR activity: Implications for immunotherapy,
Pharmacol. Ther. 165, 93-113.
37. Touma, C., Gassen, N. C., Herrmann, L., Cheung-
Flynn, J., Bull, D. R., Ionescu, I. A., Heinzmann, J. M.,
Knapman, A., Siebertz, A., Depping, A. M., Hartmann,
J., Hausch, F., Schmidt, M. V., Holsboer, F., Ising, M.,
Cox, M. B., Schmidt, U., and Rein, T. (2011) FK506
binding protein 5 shapes stress responsiveness:
modulation of neuroendocrine reactivity and coping
behavior, Biol. Psychiatry 70, 928-936.
48. Jinwal, U. K., Koren, J., 3rd, Borysov, S. I.,
Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson,
A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., 3rd, Jin,
Y., Buchner, J., Cox, M. B., and Dickey, C. A. (2010)
The Hsp90 cochaperone, FKBP51, increases Tau
stability and polymerizes microtubules, J. Neurosci.
30, 591-599.
49. Gaali, S., Kirschner, A., Cuboni, S., Hartmann, J.,
Kozany, C., Balsevich, G., Namendorf, C., Fernandez-
Vizarra, P., Sippel, C., Zannas, A. S., Draenert, R.,
Binder, E. B., Almeida, O. F., Ruhter, G., Uhr, M.,
Schmidt, M. V., Touma, C., Bracher, A., and Hausch,
F. (2015) Selective inhibitors of the FK506-binding
protein 51 by induced fit, Nat Chem Biol 11, 33-37.
50. Hartmann, J., Wagner, K. V., Gaali, S., Kirschner,
A., Kozany, C., Ruhter, G., Dedic, N., Hausl, A. S.,
Hoeijmakers, L., Westerholz, S., Namendorf, C.,
Gerlach, T., Uhr, M., Chen, A., Deussing, J. M.,
Holsboer, F., Hausch, F., and Schmidt, M. V. (2015)
Pharmacological Inhibition of the Psychiatric Risk
Factor FKBP51 Has Anxiolytic Properties, The Journal
of neuroscience : the official journal of the Society for
Neuroscience 35, 9007-9016.
51. Cluning, C., Ward, B. K., Rea, S. L., Arulpragasam,
A., Fuller, P. J., and Ratajczak, T. (2013) The helix 1-
3 loop in the glucocorticoid receptor LBD is a
regulatory element for FKBP cochaperones, Mol.
Endocrinol. 27, 1020-1035.
52. Thornton, S. L., Farnaes, L., and Minns, A. (2016)
Prolonged Antimuscarinic Delirium in a Child Due to
Benztropine Exposure Treated With Multiple Doses
of Physostigmine, Pediatric emergency care 32, 243-
245.
38. Kay, P., Schlossmacher, G., Matthews, L.,
Sommer, P., Singh, D., White, A., and Ray, D. (2011)
Loss of glucocorticoid receptor expression by DNA
methylation
prevents
glucocorticoid
induced
apoptosis in human small cell lung cancer cells, PLoS
One 6, e24839.
39. Schmitt, K. C., Zhen, J., Kharkar, P., Mishra, M.,
Chen, N., Dutta, A. K., and Reith, M. E. (2008)
Interaction
of
cocaine-,
benztropine-,
and
GBR12909-like compounds with wild-type and
mutant human dopamine transporters: molecular
features that differentially determine antagonist-
binding properties, J Neurochem 107, 928-940.
40. Tranguch, S., Cheung-Flynn, J., Daikoku, T.,
Prapapanich, V., Cox, M. B., Xie, H., Wang, H., Das,
S. K., Smith, D. F., and Dey, S. K. (2005) Cochaperone
immunophilin FKBP52 is critical to uterine
receptivity for embryo implantation, Proc. Natl.
Acad. Sci. U. S. A. 102, 14326-14331.
41. Hartmann, J., Wagner, K. V., Dedic, N.,
Marinescu, D., Scharf, S. H., Wang, X. D., Deussing,
J. M., Hausch, F., Rein, T., Schmidt, U., Holsboer, F.,
Muller, M. B., and Schmidt, M. V. (2012) Fkbp52
heterozygosity alters behavioral, endocrine and
neurogenetic parameters under basal and chronic
stress conditions in mice, Psychoneuroendocrinology
37, 2009-2021.
42. Schaaf, M. J., and Cidlowski, J. A. (2003)
Molecular determinants of glucocorticoid receptor
13
ACS Paragon Plus Environment